Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer's dementia: a randomized controlled trial. Alzforum, 03 Feb 2023 Wunderlich G, Blahova Z, Garcia M, Jessen F. Alzheimers Res Ther. 2023 Jan 28;15(1):24.